Letter to the Editor From de Ponthaud et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival"

J Clin Endocrinol Metab. 2022 Jul 14;107(8):e3538-e3539. doi: 10.1210/clinem/dgac050.

Authors

Charles de Ponthaud^{1

2

3}, Nathalie Chéreau^{1

3}, Fabrice Menegaux^{1

3}, Sébastien Gaujoux^{1

2

3}

Affiliations

¹ Department of General, Visceral, and Endocrine Surgery, Pitié-Salpêtrière Hospital, AP-HP, Paris, France.
² Department of Hepato-Biliary and Pancreatic Surgery and Liver Transplantation, AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
³ Sorbonne University, Paris, France.

PMID: 35171248
DOI: 10.1210/clinem/dgac050

No abstract available

Keywords: adrenocortical carcinoma; cytoreductive surgery; overall survival.

Publication types

Letter
Comment

MeSH terms

Adrenal Cortex Neoplasms* / surgery
Adrenocortical Carcinoma* / surgery
Carcinoma, Renal Cell* / pathology
Cytoreduction Surgical Procedures
Humans
Kidney Neoplasms* / pathology